- Home
- BMEA vs DLTH Comparison
BMEA vs DLTH Comparison
Compare BMEA & DLTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMEA
- DLTH
- Stock Information
- Founded
- BMEA 2017
- DLTH 1989
- Country
- BMEA United States
- DLTH United States
- Employees
- BMEA N/A
- DLTH N/A
- Industry
- BMEA Biotechnology: Pharmaceutical Preparations
- DLTH Clothing/Shoe/Accessory Stores
- Sector
- BMEA Health Care
- DLTH Consumer Discretionary
- Exchange
- BMEA Nasdaq
- DLTH Nasdaq
- Market Cap
- BMEA 65.8M
- DLTH 71.0M
- IPO Year
- BMEA 2021
- DLTH 2015
- Fundamental
- Price
- BMEA $1.71
- DLTH $2.25
- Analyst Decision
- BMEA Strong Buy
- DLTH Hold
- Analyst Count
- BMEA 10
- DLTH 1
- Target Price
- BMEA $21.00
- DLTH $2.75
- AVG Volume (30 Days)
- BMEA 1.1M
- DLTH 44.6K
- Earning Date
- BMEA 08-04-2025
- DLTH 08-28-2025
- Dividend Yield
- BMEA N/A
- DLTH N/A
- EPS Growth
- BMEA N/A
- DLTH N/A
- EPS
- BMEA N/A
- DLTH N/A
- Revenue
- BMEA N/A
- DLTH $612,649,000.00
- Revenue This Year
- BMEA N/A
- DLTH N/A
- Revenue Next Year
- BMEA N/A
- DLTH $0.55
- P/E Ratio
- BMEA N/A
- DLTH N/A
- Revenue Growth
- BMEA N/A
- DLTH N/A
- 52 Week Low
- BMEA $1.29
- DLTH $1.58
- 52 Week High
- BMEA $13.07
- DLTH $4.50
- Technical
- Relative Strength Index (RSI)
- BMEA 41.35
- DLTH 51.95
- Support Level
- BMEA $1.65
- DLTH $2.26
- Resistance Level
- BMEA $1.85
- DLTH $2.45
- Average True Range (ATR)
- BMEA 0.11
- DLTH 0.13
- MACD
- BMEA -0.01
- DLTH -0.00
- Stochastic Oscillator
- BMEA 5.56
- DLTH 38.46
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases. The company uses its proprietary FUSION System discovery platform to develop a pipeline of novel small-molecule product candidates. Its principal clinical program's drug candidate, icovamenib, is being developed as an orally bioavailable, selective covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity. The company is also developing BMF-650, an investigational, oral small-molecule GLP-1 RA, which has the potential to be a therapeutic option for diabetes and obesity.
About DLTH Duluth Holdings Inc. Class B
Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.